The emergence, genomic diversity and global spread of SARS-CoV-2

J Li, S Lai, GF Gao, W Shi - Nature, 2021 - nature.com
Since the first cases of COVID-19 were documented in Wuhan, China in 2019, the world has
witnessed a devastating global pandemic, with more than 238 million cases, nearly 5 million …

The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality

TH Karlsen, N Sheron, S Zelber-Sagi, P Carrieri… - The Lancet, 2022 - thelancet.com
Executive summary Liver diseases have become a major health threat across Europe, and
the face of European hepatology is changing due to the cure of viral hepatitis C and the …

A worldwide assessment of changes in adherence to COVID-19 protective behaviours and hypothesized pandemic fatigue

A Petherick, R Goldszmidt, EB Andrade… - Nature Human …, 2021 - nature.com
As the COVID-19 pandemic lingers, the possibility of 'pandemic fatigue'has raised worldwide
concerns. Here, we examine whether there was a gradual reduction in adherence to …

Genomics and epidemiology of the P. 1 SARS-CoV-2 lineage in Manaus, Brazil

NR Faria, TA Mellan, C Whittaker, IM Claro… - Science, 2021 - science.org
Cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in
Manaus, Brazil, resurged in late 2020 despite previously high levels of infection. Genome …

[HTML][HTML] COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics

M Schwarzinger, V Watson, P Arwidson… - The Lancet Public …, 2021 - thelancet.com
Background Opinion polls on vaccination intentions suggest that COVID-19 vaccine
hesitancy is increasing worldwide; however, the usefulness of opinion polls to prepare mass …

Inferring the effectiveness of government interventions against COVID-19

JM Brauner, S Mindermann, M Sharma, D Johnston… - Science, 2021 - science.org
INTRODUCTION Governments across the world have implemented a wide range of
nonpharmaceutical interventions (NPIs) to mitigate the spread of severe acute respiratory …

[HTML][HTML] Reduction in mobility and COVID-19 transmission

P Nouvellet, S Bhatia, A Cori, KEC Ainslie… - Nature …, 2021 - nature.com
In response to the COVID-19 pandemic, countries have sought to control SARS-CoV-2
transmission by restricting population movement through social distancing interventions …

Testing at scale during the COVID-19 pandemic

TR Mercer, M Salit - Nature Reviews Genetics, 2021 - nature.com
Assembly and publication of the severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) genome in January 2020 enabled the immediate development of tests to detect the …

[图书][B] Sustainable development report 2022

J Sachs, C Kroll, G Lafortune, G Fuller, F Woelm - 2022 - books.google.com
The Sustainable Development Report 2022 features the SDG Index and Dashboards, the
first and widely used tool to assess country performance on the Agenda 2030 and the …

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled …

Y Zhang, G Zeng, H Pan, C Li, Y Hu, K Chu… - The Lancet infectious …, 2021 - thelancet.com
Background With the unprecedented morbidity and mortality associated with the COVID-19
pandemic, a vaccine against COVID-19 is urgently needed. We investigated CoronaVac …